CurveBeam AI raises US$3.24M placement, adds US$647.1K share plan
What's the deal? CurveBeam AI (ASX: CBE) has completed a fully subscribed US$3.24M placement to institutional and sophisticated investors at US$0.65 per share. The medical imaging company also declared a US$647.1K share purchase plan (SPP) for eligible shareholders.
The details: The SPP lets existing shareholders buy additional shares at a 10% discount to the placement price. Both the placement and SPP are subject to shareholder approval and regulatory clearances.
What's the endgame? CurveBeam builds AI-driven medical imaging tools. It said the funds will accelerate product development, expand market access, and strengthen its balance sheet.
The signal: A quick post-IPO re-raise signals CurveBeam is topping up capital to press ahead on commercialisation, tapping both large investors and its shareholder base rather than waiting for a larger single round.
Read more: AInvest
